To test whether hyperinsulinemia and continuously elevated receptor signaling acted as a major driver of increased basal tyrosine phosphorylation levels, we used a liver insulin receptor knockout model (LIRKO, Fig 5A; Michael et al, 2000). The gene discussed is INSR; the disease is Hyperinsulinemia.